Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5881138 | 0.89 | NOD1 (0.48) | GNPATDPP4NOD1MMEENPEP | |
| SCHEMBL18885574 | 0.87 | GNPAT (0.47) | GNPATDPP4NOD1ENPEPDPP8 | |
| SCHEMBL30355295 | 0.86 | MME (0.49) | GNPATNOD1MMEENPEP | |
| SCHEMBL8650914 | 0.86 | MME (0.49) | GNPATNOD1MMEENPEP | |
| SCHEMBL7825934 | 0.86 | MME (0.49) | GNPATNOD1MMEENPEP | |
| SCHEMBL8648570 | 0.86 | MME (0.49) | GNPATNOD1MMEENPEP | |
| SCHEMBL29378709 | 0.86 | MME (0.49) | GNPATNOD1MMEENPEP | |
| SCHEMBL23408821 | 0.84 | MME (0.42) | GNPATMME | |
| SCHEMBL31332251 | 0.83 | BMP1 (0.50) | GNPATDPP4NOD1MMEENPEP | |
| SCHEMBL30798028 | 0.83 | GNPAT (0.53) | GNPATNOD1MMEENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147484-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | BICYCLETX LIMITED (GB) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147484-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | VIP, NGLY1, BID | GNPAT 3005/4885DPP4 160/4885NOD1 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.